G. Avallone

发表

Microenvironment in cutaneous melanomas: a gene expression profile study may explain the role of histological regression

M. Papotti, R. Senetta, P. Cassoni, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma

M. Aglietta, P. Quaglino, S. Ribero, 2022, Journal of clinical medicine.

Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association

P. Quaglino, S. Ribero, M. Fierro, 2022, Dermatologic therapy.

Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review

I. Zalaudek, C. Dianzani, S. Morariu, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Tocilizumab and its usage for skin diseases

P. Quaglino, S. Ribero, M. Fierro, 2022, Italian Journal of Dermatology and Venereology.

Risankizumab shows high efficacy and maintenance in improvement of response until week 52

G. Fabbrocini, M. Megna, P. Quaglino, 2022, Dermatologic therapy.

Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System

R. Senetta, S. Giordano, P. Quaglino, 2022, Cells.

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

A. Calcagno, P. Quaglino, S. Ribero, 2022, Acta dermato-venereologica.

Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study

I. Stanganelli, P. Quaglino, M. Medri, 2022, Dermatologic therapy.

Imiquimod‐side effects in the treatment of periocular skin cancers: A review of the literature

I. Zalaudek, P. Quaglino, S. Ribero, 2022, Dermatologic therapy.

Extensive “halo naevi” phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?

I. Zalaudek, S. Giordano, P. Quaglino, 2022, Dermatologic therapy.

Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications

R. Senetta, P. Quaglino, S. Ribero, 2021, International journal of molecular sciences.

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

P. Quaglino, S. Ribero, A. Marzano, 2023, Journal of clinical medicine.

Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report

L. Lopiano, P. Quaglino, S. Ribero, 2021, Acta dermato-venereologica.

Lichen ruber planus arising during dupilumab treatment for atopic dermatitis.

P. Quaglino, S. Ribero, M. Ortoncelli, 2022, Italian journal of dermatology and venereology.

Perspectives of Immunotherapy in Non-Melanoma Skin Cancers

P. Quaglino, S. Ribero, P. Fava, 2021 .

Immunotherapy in transplanted patients: A special population that can no longer be ignored

L. Biancone, P. Quaglino, S. Ribero, 2021, Dermatologic therapy.

Melanoma Management during the COVID-19 Pandemic Emergency: A Literature Review and Single-Center Experience

I. Stanganelli, P. Quaglino, G. Gualdi, 2021, Cancers.

Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study

P. Quaglino, S. Ribero, M. Ortoncelli, 2021, The Journal of dermatological treatment.

Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?

P. Quaglino, S. Ribero, G. Avallone, 2022, Dermatologic therapy.

Attitudes, characteristics, and occupational‐related risk of skin cancer and cutaneous melanoma in the militaries: an observational, cross‐sectional, survey‐based study

P. Quaglino, S. Ribero, G. Avallone, 2022, International journal of dermatology.

Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience

I. Zalaudek, A. Di Stefani, R. Senetta, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review

I. Zalaudek, P. Quaglino, S. Ribero, 2022, International journal of dermatology.

Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single‐centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course

P. Quaglino, S. Ribero, P. Fava, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study

R. Senetta, P. Quaglino, S. Ribero, 2022, Acta dermato-venereologica.

Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic

P. Quaglino, C. Moltrasio, S. Ribero, 2022, Frontiers in Medicine.

Reply to ‘The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al.

R. Senetta, P. Quaglino, S. Ribero, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinical spectrum of human monkeypox: An Italian single‐centre case series

G. Avallone, C. A. Maronese, F. Boggio, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Unilesional monkeypox: A report of two cases from Italy

M. Cusini, A. Marzano, G. Avallone, 2022, Travel medicine and infectious disease.

Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy

M. Cusini, A. Gori, A. Marzano, 2022, The British journal of dermatology.

Maculopapular rash: An overlooked monkeypox diagnostic clue?

P. Quaglino, S. Ribero, A. Marzano, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Syphilis and monkeypox co-infection: Coincidence, synergy or asymptomatic carriage?

A. Marzano, G. Avallone, C. A. Maronese, 2022, Travel medicine and infectious disease.

Dupilumab‐induced Urticaria

G. Rolla, P. Quaglino, S. Ribero, 2021, Dermatologic therapy.

Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks

P. Quaglino, S. Ribero, M. Ortoncelli, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study

P. Quaglino, S. Ribero, M. Ortoncelli, 2021, Dermatologic therapy.

Topical ruxolitinib: A new treatment for vitiligo

I. Zalaudek, P. Quaglino, S. Ribero, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real‐life study

P. Quaglino, S. Ribero, M. Ortoncelli, 2022, Dermatologic therapy.

Real‐world data on primary cutaneous lymphoproliferative disorders following SARS‐CoV‐2 vaccination: A multicentre experience from tertiary referral hospitals

I. Zalaudek, A. Pileri, P. Quaglino, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Non-Sentinel Lymph Node Detection during Sentinel Lymph Node Biopsy in Not-Complete-Lymph-Node-Dissection Era: A New Technique for Better Staging and Treating Melanoma Patients

R. Senetta, P. Quaglino, S. Ribero, 2021, Journal of clinical medicine.

Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients

P. Quaglino, S. Ribero, M. Ortoncelli, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dermoscopy as a supportive diagnostic tool in human monkeypox

E. Errichetti, G. Avallone, C. A. Maronese, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Mpox: an updated review of dermatological manifestations in the current outbreak.

A. Marzano, G. Avallone, C. A. Maronese, 2023, The British journal of dermatology.

Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?

P. Quaglino, S. Ribero, G. Avallone, 2021, The Journal of dermatological treatment.

Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult‐to‐treat population

P. Quaglino, S. Ribero, G. Avallone, 2022, British Journal of Dermatology.

Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin

P. Quaglino, S. Ribero, P. Fava, 2022, The British journal of dermatology.

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center

B. Pasini, P. Quaglino, S. Ribero, 2023, Cancers.

BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: a novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome.

B. Pasini, P. Quaglino, S. Ribero, 2022, Melanoma research.

BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors

V. de Giorgi, M. Mandalà, D. Massi, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

F. Valvo, P. Quaglino, V. Vitolo, 2021, Oncotarget.

Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini‐melanoma): a retrospective multicentric study of 269 cases

A. Lallas, G. Argenziano, G. Pellacani, 2023, International Journal of Dermatology.

Dermoscopy of dermal duct tumour

G. Nazzaro, A. Marzano, G. Avallone, 2022, The Australasian journal of dermatology.

Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lata.

R. Senetta, P. Quaglino, S. Ribero, 2022, Italian journal of dermatology and venereology.

Synchronous occurrence of primary cutaneous B‐cell lymphoma and cutaneous Rosai–Dorfman disease in distinct lesions: A unique association

P. Quaglino, S. Ribero, P. Fava, 2023, Journal of cutaneous pathology.

Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.

P. Quaglino, S. Ribero, M. Ortoncelli, 2022, Clinical and experimental dermatology.

Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas

P. Fava, G. Avallone, E. Zavattaro, 2024, JEADV Clinical Practice.